Rosuvastatin Calcium
Brand names: Crestor, Rosuvastatin Calcium
Part of: Statins
At a glance
- Medicare prescriptions, 2024
- 29,787,376
- Medicare drug cost
- $426.1M
- Average cost per prescription
- $14.30
- Clinicians who prescribed it
- 258,412
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Rosuvastatin tablets are indicated: To reduce the risk of major adv ers e cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults at increased risk for CV events. As an adjunct to diet and exe rci se to reduce low-density lipoprotein cholesterol (LDL-C): in adults with hypercholesterolemia. and slow the progression of atherosclerosis in adults. in adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH). in adults and pediatric patients aged 7 years and older with homozygous familial hypercholesterolemia (HoFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia. Hypertriglyceridemia.
From the FDA-approved prescribing information (label dated August 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Family Medicine 30.8%
- Internal Medicine 27.1%
- Nurse Practitioners 15.0%
- Cardiology 11.0%
- Physician Assistants 5.7%
- Interventional Cardiology 3.7%
- General Practice 1.6%
- Endocrinology & Diabetes 1.4%
- Geriatric Medicine 1.0%
- Nephrology (Kidney) 0.4%
- Cardiac Electrophysiology 0.3%
- Hospitalist 0.3%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 134% from 2019 to 2024.
Biggest change by state since 2019
- Idaho +215%
- Nevada +212%
- Utah +195%
- Oregon +189%
- Minnesota +188%
- New York (smallest change) +82%
- West Virginia (smallest change) +86%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 5 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
AstraZeneca Pharmaceuticals LP
| Strength | Looks like | Imprint |
|---|---|---|
| 5 mg | yellow round tablet, 7 mm | ZD4522 5 |
| 10 mg | pink round tablet, 7 mm | ZD4522 10 |
| 20 mg | pink round tablet, 9 mm | ZD4522 20 |
| 40 mg | pink oval tablet, 11 mm | ZD4522 40 |
Biocon Pharma Inc
| Strength | Looks like | Imprint |
|---|---|---|
| 5 mg | yellow round tablet, 7 mm | 5 B |
| 10 mg | pink round tablet, 7 mm | 10 B |
| 20 mg | pink round tablet, 9 mm | 20 B |
| 40 mg | pink oval tablet, 12 mm | 40 B |
Cranbury Pharmaceuticals, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 5 mg | pink round tablet, 7 mm | CY 5 |
| 10 mg | yellow round tablet, 7 mm | CY 10 |
| 20 mg | yellow round tablet, 9 mm | CY 20 |
| 40 mg | pink round tablet, 9 mm | CY 40 |
Redpharm Drug
| Strength | Looks like | Imprint |
|---|---|---|
| 10 mg | pink round tablet, 5 mm | R10 |
Rising Pharma Holdings, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 5 mg | pink oval tablet, 6 mm | I 29 |
| 10 mg | pink round tablet, 6 mm | I 30 |
| 20 mg | pink round tablet, 7 mm | I 31 |
| 40 mg | pink oval tablet, 12 mm | I 32 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
3 recalls since 2020
- Dec 2025 · Avkare · Class II
Out of specification for dissolution. - Mar 2025 · Glenmark Pharmaceuticals Inc., USA · Class II
CGMP Deviations - Feb 2023 · Accord Healthcare, Inc. · Class II
CGMP Deviations: recalling drug products following an FDA inspection.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.